Bulletin du Cancer
Volume 91, issue 1, Janvier 2004
Éditorial
Éditorial
(p.7-8)
Paul Cappelaere
Synthèse
Frequency of cancer in France: 2004 update
(p.9-14)
Catherine Hill, Françoise Doyon
RNA interference and its possible use in cancer therapy
(p.15-8)
Slimane Ait‐Si‐Ali, Valentina Guasconi, Annick Harel‐Bellan
Recent advances in pharmacogenomics in oncology
(p.19-28)
Jacques Robert, Jacques Bonnet
Cytogenetics, cytogenomics and cancer: 2004 update
(p.29-43)
Alain Bernheim, Jean‐Louis Huret, Marine Guillaud‐Bataille, Olivier Brison, Jérôme Couturier et le Groupe français de cytogénétique oncologique
Optical diagnosis of cervical dysplasia
(p.45-53)
Igor Charvet, Paolo Meda, Magalie Genet, Marie‐Françoise Pelte, Anne‐Thérèse Vlastos
Neoadjuvant endocrine therapy for breast cancer: an overview
(p.55-62)
Julien Domont, Moise Namer, David Khayat, Jean‐Philippe Spano
Cyclooxygenase 2 and carcinogenesis
(p.61-76)
Sylvie Rodrigues, Erik Bruyneel, Christelle M. Rodrigue, Emami Shahin, Christian Gespach
Adjuvant chemotherapy in non‐small cell lung cancer
(p.63-7)
Laurent Taillade, Jean‐Charles Soria, Fabrice André, Dominique Grunenwald, Ariane Dunant, Jean‐Pierre Pignon, Thierry Le Chevalier
Hormone therapy for prostate cancer
(p.69-74)
Christine Théodore
Colon cancer: what is new in 2004?
(p.75-80)
Thierry André, Christophe Louvet, Aimery de Gramont
Cyclooxygenase 2 inhibitors and cancer chemoprevention
(p.77-84)
Amine Masmoudi, Thierry Le Chevalier, Laure Sabatier, Jean‐Charles Soria
Radiosurgery of brain metastasis: reflexions, controversies and unanswered questions in 2004
(p.81-93)
Georges Noël, Gilbert Boisserie, Loïc Feuvret, Jean‐Jacques Mazeron
Cyclooxygenase 2 inhibitors and adenomatous polyposis coli
(p.85-8)
Christian Florent, Nathalie Meary
Cyclooxygenase 2 inhibitors and colorectal cancer
(p.89-98)
Marianne Bernardeau‐Mozer, Stanislas Chaussade
What‘s new in the treatment of cancer pain?
(p.95-8)
Mario Di Palma, Philippe Poulain, Évelyne Pichard
Psycho‐oncology and the present tasks of psycho‐oncologists
(p.99-104)
Daniel Oppenheim, Sarah Dauchy
Cyclooxygenase 2 and breast cancer
(p.99-108)
Jean‐Paul Guastalla, Thomas Bachelot, Isabelle Ray‐Coquard
Cyclooxygenase 2 inhibitors and lung carcinoma
(p.109-12)
Jean‐Philippe Spano, Kader Chouahnia, Jean‐François Morère
Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers
(p.113-6)
Pascal Eschwege
Safety of the selective inhibitors the inducible cyclooxygenase-2 taken for long period
(p.117-24)
Dominique Lamarque
Analgesic effects of cyclooxygenase 2 inhibitors
(p.125-31)
Christian Jayr
COMPTE RENDU DE CONGRÈS
45
e congrès de l‘American Society of Therapeutic Radiology and Oncology (Astro) Salt Lake City, 19‐23 octobre 2003
(p.105-15)
Jean‐Jacques Mazeron, Séverine Racadot
Editorial
Inhibiteurs de la cyclo‐oxygénase 2 et cancer
(p.59-60)
Thierry André, Jean‐Charles Soria